Table 2 Morphometric parameters of NMJs in untreated, IgG- and CCL2 neutralising antibody-treated GC muscles

From: The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis

Morphometric parameters

ALS untreated

ALS IgG-treated

ALS CCL2 neutr.

Presynaptic parameters

Axon diameter (µm)

1.05 ± 0.09

1.39 ± 0.08 (p = 0.0002)

1.37 ± 0.14 (p = 0.0003)

Nerve terminal area (µm2)

93.07 ± 13.15

130.10 ± 16.32 (p = 0.0010)

131.99 ± 11.76 (p = 0.0007)

Nerve terminal perimeter (µm)

169.25 ± 22.94

235.22 ± 24.08 (p = 0.0004)

225.51 ± 15.65 (p = 0.0014)

Nerve terminal complexity (a.u.)

4.63 ± 0.17

5.11 ± 0.30 (p = 0.0022)

4.95 ± 0.07 (p = 0.0238)

Postsynaptic parameters

AChR area (µm2)

351.31 ± 43.06

375.75 ± 31.99

349.90 ± 26.27

AChR perimeter (µm)

128.54 ± 14.80

137.80 ± 25.70

125.48 ± 8.82

Endplate area (µm2)

415.26 ± 47.01

440.30 ± 38.71

415.30 ± 31.45

Endplate perimeter (µm)

85.28 ± 5.37

87.42 ± 4.86

84.37 ± 3.42

Endplate diameter (µm)

33.02 ± 2.82

32.71 ± 1.78

32.17 ± 2.98

Compactness (a.u.)

84.51 ± 1.37

85.34 ± 1.78

84.37 ± 1.32

Fragmentation (a.u.)

0.12 ± 0.06

0.12 ± 0.10

0.11 ± 0.05

Others

Area of synaptic contact (µm2)

88.45 ± 12.45

125.43 ± 15.33 (p = 0.0005)

127.77 ± 9.34 (p = 0.0003)

Overlap (%)

25.45 ± 3.38

34.54 ± 4.27 (p = 0.0014)

37.03 ± 2.92 (p = 0.0002)

  1. Values represent mean ± sem. Statistically significant differences are highlighted in bold, with p values. In each case, treated groups were compared to the untreated contralateral values. Statistical analysis was performed with n = 7 (untreated) and n = 4 (IgG, CCL2) mice/group. 30-40 NMJs were analysed per muscle. Based on normality tests, parametric one-way ANOVA with Fisher’s LSD post-hoc was used out for axon diameter, nerve terminal area, nerve terminal perimeter, nerve terminal complexity, AChR area, endplate area, endplate perimeter, endplate diameter, fragmentation, area of synaptic contact and overlap variables and Kruskal-Wallis test with uncorrected Dunn’s post-hoc was used for AChR perimeter [Shapiro-Wilk normality test, ALS untreated group: p = 0.0244, ALS IgG group: p = 0.8536, ALS CCL2 group p = 0.5031] and compactness [Shapiro-Wilk normality test, ALS untreated group: p = 0.9778, ALS IgG group: p = 0.4864, ALS CCL2 group p = 0.0381]. a.u = arbitrary unit, neutr = neutralisation.